Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole

Veterinary Parasitology

Volumn 155, Issue 1-2, 2008, Pages 49-58

  Halferty, L ^a   Brennan, G P ^a   Hanna, R E B ^b   Edgar, H W ^b   Meaney, M M ^a   McConville, M ^a   Trudgett, A ^a   Hoey, L ^a   Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

Author keywords

Fasciola hepatica; Liver fluke; Scanning electron microscopy; Triclabendazole

Indexed keywords

TRICLABENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; FASCIOLA HEPATICA; FASCIOLIASIS; IN VIVO STUDY; INTEGUMENT; MORPHOLOGY; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SKIN EXFOLIATION; SYNCYTIUM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; FASCIOLA HEPATICA; FASCIOLIASIS; INTEGUMENTARY SYSTEM; MOLECULAR STRUCTURE; SHEEP; SHEEP DISEASES;

FASCIOLA HEPATICA; OVIS ARIES;

EID: 45549086280     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2008.04.011     Document Type: Article

References (34)

1. Anderson H.R., and Fairweather I. Fasciola hepatica: scanning electron microscopic observations of juvenile flukes following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide (DAMD). Int. J. Parasitol. 18 (1988) 827-837
2. Anderson H.R., and Fairweather I. Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with deacetylated (amine) metabolite of diamphenethide. Int. J. Parasitol. 25 (1995) 319-333
3. Behm C.A., and Sangster N.C. Pathology, pathophysiology and clinical aspects. In: Dalton J.P. (Ed). Fasciolosis (1999), CAB International, Wallingford 185-224
4. Bennett C.E., Hughes D.L., and Harness E. Fasciola hepatica: changes in tegument during killing of adult flukes surgically transferred to sensitised rats. Parasite Immunol. 2 (1980) 39-55
5. Boray J.C. Disease of Domestic Animals Caused by Flukes (1994), Food and Agricultural Organisation of the Untied Nations, Rome 49 pp
6. Boray J.C., Crowfoot P.D., Strong M.B., Allison J.R., Schellenbaum M., von Orelli M., and Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Rec. 113 (1983) 315-317
7. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J. Helminthol. 79 (2005) 227-234
8. Fairweather I., Anderson H.R., and Threadgold L.T. Fasciola hepatica: tegumental changes induced in vitro by the deacetylated (amine) metabolite of diamphenethide. Exp. Parasitol. 62 (1986) 336-348
9. Fairweather I., Anderson H.R., and Baldwin T.M.A. Fasciola hepatica: tegumental surface alterations following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide. Parasitol. Res. 73 (1987) 99-106
10. Fairweather I., Holmes S.D., and Threadgold L.T. Fasciola hepatica: motility responses to fasciolicides in vitro. Exp. Parasitol. 57 (1984) 209-224
11. Fairweather I., Threadgold L.T., and Hanna R.E.B. Development of Fasciola hepatica in the mammalian host. In: Dalton J.P. (Ed). Fasciolosis (1999), CAB International, Wallingford 47-111
12. Hanna R.E.B. Fasciola hepatica: glycocalyx replacement in the juvenile as a possible mechanism for protection against host immunity. Exp. Parasitol. 50 (1980) 103-114
13. Hanna R.E.B. Fasciola hepatica: an immunofluorescent study of antigenic changes in the tegument during development in the rat and the sheep. Exp. Parasitol. 50 (1980) 155-170
14. Hennessy D.R., Lacey E., Steel J.W., and Prichard R.K. The kinetics of triclabendazole disposition in sheep. J. Vet. Pharmacol. Ther. 10 (1987) 64-72
15. Mas-Coma S., Bargues M.D., and Valero M.A. Fascioliasis and other plant-borne trematode zoonoses. Int. J. Parasitol. 35 (2005) 1255-1278
16. McConville M., Brennan G.P., McCoy M., Castillo R., Hernandez-Campos A., Ibarra F., and Fairweather I. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitology 133 (2006) 195-208
17. McConville M., Brennan G.P., McCoy M., Castillo R., Hernandez-Campos A., Ibarra F., and Fairweather I. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitol. Res. 100 (2007) 365-377
18. McCoy M.A., Fairweather I., Brennan G.P., Kenny J.M., Ellison S., and Forbes A.F. The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabendazole-resistant Fasciola hepatica in sheep. Res. Vet. Sci. 78 Suppl. A (2005) 33
19. McKinstry B., Fairweather I., Brennan G.P., and Forbes A.B. Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax). Parasitol. Res. 91 (2003) 251-263
20. McKinstry B., Brennan G.P., Halferty L., Forbes A.B., and Fairweather I. Ultrastructural changes induced in the tegument and gut of Fasciola hepatica after in vivo and in vitro drug treatment with nitroxynil (Trodax). Parasitol. Res. 101 (2007) 929-941
21. Meaney M., Fairweather I., Brennan G.P., McDowell L.S.L., and Forbes A.B. Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes. Parsitol. Res. 91 (2003) 238-250
22. Meaney M., Fairweather I., Brennan G.P., and Forbes A.B. Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon. Parasitol. Res. 92 (2004) 232-241
23. Meaney M., Allister J., McKinstry B., McLaughlin K., Brennan G.P., Forbes A.B., and Fairweather I. Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitol. Res. 99 (2006) 609-621
24. Mestorino N., Formentini E.A., Lucas M.F., Fernandez C., Modamio P., Mariño Hernández E., and Errecalde J.O. Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide. Vet. Res. Commun. 32 (2008) 21-33
25. Mitchell G.B.B. Update on fasciolosis in cattle and sheep. In Pract. 24 (2002) 378-385
26. Mottier L., Virkel G., Solana H., Alvarez L., Salles J., and Lanusse C.E. Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica. Xenobiotica 34 (2004) 1043-1057
27. Mottier L., Alvarez L., Ceballos L., and Lanusse C. Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics. Exp. Parasitol. 113 (2006) 49-57
28. Robinson M.W., Trudgett A., Hoey E.M., and Fairweather I. Triclabendazole-resistant Fasciola hepatica: ß-tubulin and response to in vitro treatment with triclabendazole. Parasitology 124 (2002) 325-338
29. Robinson M.W., Lawson J., Trudgett A., Hoey E.M., and Fairweather I. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol. Res. 92 (2004) 205-210
30. Smeal M.G., and Hall C.A. The activity of triclabendazole against immature and adult Fasciola hepatica infections in sheep. Aust. Vet. J. 60 (1983) 329-331
31. Stitt A.W., and Fairweather I. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex). Parasitol. Res. 79 (1993) 529-536
32. Stitt A.W., and Fairweather I. The effect of the sulphoxide metabolite of triclabendazole ("Fasinex") on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica. Parasitology 108 (1994) 555-567
33. Turner K., Armour J., and Richards R.J. Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep. Vet. Rec. 114 (1984) 41-42
34. Virkel G., Lifschitz A., Sallovitz J., Pis A., and Lanusse C. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep. J. Vet. Pharmacol. Ther. 29 (2006) 213-223